Trial
NCT06354023
Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis
Phase IISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
John Sledge
Collaborators
—
Condition
Osteoarthritis, Knee
Intervention
Recombinant human growth hormone
Why stopped
The study has been placed on a clinical hold by the FDA.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-04